Probing Unexpected Reactivity in Radiometal Chemistry: Indium-111-Mediated Hydrolysis of Hybrid Cyclen-Hydroxypyridinone Ligands

探索放射性金属化学中意想不到的反应活性:铟-111介导的杂化环烯-羟基吡啶酮配体的水解

阅读:2

Abstract

Chelators based on hydroxypyridinones have utility in incorporating radioactive metal ions into diagnostic and therapeutic agents used in nuclear medicine. Over the course of our hydroxypyridinone studies, we have prepared two novel chelators, consisting of a cyclen (1,4,7,10-tetraazacyclododecane) ring bearing two pendant hydroxypyridinone groups, appended via methylene acetamide motifs at either the 1,4-positions (L(1)) or 1,7-positions (L(2)) of the cyclen ring. In radiolabeling reactions of L(1) or L(2) with the γ-emitting radioisotope, [(111)In]In(3+), we have observed radiometal-mediated hydrolysis of a single amide group of either L(1) or L(2). The reaction of either [(111)In]In(3+) or [(nat)In]In(3+) with either L(1) or L(2), in aqueous alkaline solutions at 80 °C, initially results in formation of [In(L(1))](+) or [In(L(2))](+), respectively. Over time, each of these species undergoes In(3+)-mediated hydrolysis of a single amide group to yield species in which In(3+) remains coordinated to the resultant chelator, which consists of a cyclen ring bearing a single hydroxypyridinone group and a single carboxylate group. The reactivity toward hydrolysis is higher for the L(1) complex compared to that for the L(2) complex. Density functional theory calculations corroborate these experimental findings and importantly indicate that the activation energy required for the hydrolysis of L(1) is significantly lower than that required for L(2). This is the first reported example of a chelator undergoing radiometal-mediated hydrolysis to form a radiometalated complex. It is possible that metal-mediated amide bond cleavage is a source of instability in other radiotracers, particularly those in which radiometal complexation occurs in aqueous, basic solutions at high temperatures. This study highlights the importance of appropriate characterization of radiolabeled products.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。